Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Long Term Immunogenicity Study of Engerix-B Vaccine in 10 Year Old Children and the Effect of Booster Injections

This study has been completed.
Sponsor:
Collaborators:
Institut National en Santé Publique du Québec
Centre de Recheche du Centre Hospitalier Université Laval
SmithKlinBeecham Biologicals
Information provided by (Responsible Party):
Vladimir Gilca, Laval University
ClinicalTrials.gov Identifier:
NCT00169858
First received: September 13, 2005
Last updated: May 24, 2013
Last verified: May 2013